{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T02:45:41Z","timestamp":1766371541053,"version":"3.48.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,21]]},"DOI":"10.7759\/cureus.99789","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T02:42:47Z","timestamp":1766371367000},"source":"Crossref","is-referenced-by-count":0,"title":["Stepwise Management of Refractory Ventricular Arrhythmias in Desmoplakin Cardiomyopathy: A Case Report"],"prefix":"10.7759","author":[{"given":"Grace","family":"Ibitamuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica D","family":"Wittwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben J","family":"Crespo-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio A","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan T","family":"Wanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae571","article-title":"Clinical features and outcomes in carriers of pathogenic desmoplakin variants","volume":"46","author":"Gasperetti A","year":"2025","unstructured":"Gasperetti A, Carrick RT, Protonotarios A, et al.. Clinical features and outcomes in carriers of pathogenic desmoplakin variants. Eur Heart J. 2025, 46:362-76. 10.1093\/eurheartj\/ehae571","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith ED","year":"2020","unstructured":"Smith ED, Lakdawala NK, Papoutsidakis N, et al.. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation. 2020, 141:1872-84. 10.1161\/CIRCULATIONAHA.119.044934","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0428-2","article-title":"Epidemiology of the inherited cardiomyopathies","volume":"18","author":"McKenna WJ","year":"2021","unstructured":"McKenna WJ, Judge DP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol. 2021, 18:22-36. 10.1038\/s41569-020-0428-2","journal-title":"Nat Rev Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0407-1","article-title":"Arrhythmogenic cardiomyopathy","volume":"11","author":"Pilichou K","year":"2016","unstructured":"Pilichou K, Thiene G, Bauce B, et al.. Arrhythmogenic cardiomyopathy. Orphanet J Rare Dis. 2016, 11:33. 10.1186\/s13023-016-0407-1","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020524","article-title":"Hypertrophic, dilated, and arrhythmogenic cardiomyopathy: Where are we?","volume":"11","author":"El Hadi H","year":"2023","unstructured":"El Hadi H, Freund A, Desch S, Thiele H, Majunke N. Hypertrophic, dilated, and arrhythmogenic cardiomyopathy: Where are we?. Biomedicines. 2023, 11:524. 10.3390\/biomedicines11020524","journal-title":"Biomedicines"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2019.09.019","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary","volume":"16","author":"Towbin JA","year":"2019","unstructured":"Towbin JA, McKenna WJ, Abrams DJ, et al.. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary. Heart Rhythm. 2019, 16:e373-407. 10.1016\/j.hrthm.2019.09.019","journal-title":"Heart Rhythm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072660","article-title":"Desmoplakin cardiomyopathy: Comprehensive review of an increasingly recognized entity","volume":"12","author":"Brand\u00e3o M","year":"2023","unstructured":"Brand\u00e3o M, Bariani R, Rigato I, Bauce B. Desmoplakin cardiomyopathy: Comprehensive review of an increasingly recognized entity. J Clin Med. 2023, 12:2660. 10.3390\/jcm12072660","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2023.03.006","article-title":"Arrhythmogenic cardiomyopathy: Evolving diagnostic criteria and insight from cardiac magnetic resonance Imaging","volume":"19","author":"Basharat SA","year":"2023","unstructured":"Basharat SA, Hsiung I, Garg J, Alsaid A. Arrhythmogenic cardiomyopathy: Evolving diagnostic criteria and insight from cardiac magnetic resonance Imaging. Heart Fail Clin. 2023, 19:429-44. 10.1016\/j.hfc.2023.03.006","journal-title":"Heart Fail Clin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suad017","article-title":"Scarring\/arrhythmogenic cardiomyopathy","volume":"25","author":"Corrado D","year":"2023","unstructured":"Corrado D, Zorzi A, Cipriani A, et al.. Scarring\/arrhythmogenic cardiomyopathy. Eur Heart J Suppl. 2023, 25:C144-54. 10.1093\/eurheartjsupp\/suad017","journal-title":"Eur Heart J Suppl"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.000000000000054","article-title":"2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Al-Khatib SM","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.. 2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018, 138:10.1161\/CIR.000000000000054","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2024.06.014","article-title":"Association of amiodarone use prior to orthotopic heart transplant with post-transplant graft dysfunction and all-cause mortality: A systematic review and meta-analysis","volume":"31","author":"Ko E","year":"2025","unstructured":"Ko E, Ahmed M, Nudy M, et al.. Association of amiodarone use prior to orthotopic heart transplant with post-transplant graft dysfunction and all-cause mortality: A systematic review and meta-analysis. J Card Fail. 2025, 31:149-53. 10.1016\/j.cardfail.2024.06.014","journal-title":"J Card Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae074","article-title":"Continuous stellate ganglion block for ventricular arrhythmias: Case series, systematic review, and differences from thoracic epidural anaesthesia","volume":"26","author":"Dusi V","year":"2024","unstructured":"Dusi V, Angelini F, Baldi E, et al.. Continuous stellate ganglion block for ventricular arrhythmias: Case series, systematic review, and differences from thoracic epidural anaesthesia. Europace. 2024, 26:euae074. 10.1093\/europace\/euae074","journal-title":"Europace"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae021","article-title":"Electrical storm treatment by percutaneous stellate ganglion block: The STAR study","volume":"45","author":"Savastano S","year":"2024","unstructured":"Savastano S, Baldi E, Compagnoni S, et al.. Electrical storm treatment by percutaneous stellate ganglion block: The STAR study. Eur Heart J. 2024, 45:823-33. 10.1093\/eurheartj\/ehae021","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0952-8180(00)00158-6","article-title":"Differential effects of right versus left stellate ganglion block on left ventricular function in humans: An echocardiographic analysis","volume":"12","author":"Lobato EB","year":"2000","unstructured":"Lobato EB, Kern KB, Paige GB, Brown M, Sulek CA. Differential effects of right versus left stellate ganglion block on left ventricular function in humans: An echocardiographic analysis. J Clin Anesth. 2000, 12:315-8. 10.1016\/s0952-8180(00)00158-6","journal-title":"J Clin Anesth"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.007118","article-title":"Effective use of percutaneous stellate ganglion blockade in patients with electrical storm","volume":"12","author":"Tian Y","year":"2019","unstructured":"Tian Y, Wittwer ED, Kapa S, et al.. Effective use of percutaneous stellate ganglion blockade in patients with electrical storm. Circ Arrhythm Electrophysiol. 2019, 12:e007118. 10.1161\/CIRCEP.118.007118","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/447584-stepwise-management-of-refractory-ventricular-arrhythmias-in-desmoplakin-cardiomyopathy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T02:42:49Z","timestamp":1766371369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/447584-stepwise-management-of-refractory-ventricular-arrhythmias-in-desmoplakin-cardiomyopathy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.99789","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}